Nventa Pharmaceuticals Corp.
Corporate Information Research & Development PipelineInvestor Relations
             
    Technology OverviewTechology - CoVal(TM) FusionsProduct PortfolioHuman Papillomavirus - HPVHspE7 - Lead CandidateClinical DevelopmentFollow-On ProductsKey Scientific PublicationsIntellectual PropertyScientific ConferencesContact us     Scientific Conferences

Upcoming Conferences

September 1-7, 2006
23rd International Papillomavirus Conference and Clinical Workshop
Prague, Czech Republic – Two abstracts accepted:

  • Generation of potent HPV CD8 T cell immunity: Combination of Hsp65 HPV-16 fusion with poly ICLC or CpG
  • High Dose HspE7 Treatment of Anal Condyloma in Men

 

Past Conferences

September 24, 2005
2005 RRP Focus Session, Los Angeles

April 30-May 6, 2005
22nd International Papillomavirus Conference, Vancouver

May 27-30, 2005
American Society of Pediatric Otolaryngology, Las Vegas

March 19-23, 2005
The Society of Gynecologic Oncologists 2005 Annual Meeting on Women's Cancer, Miami

February 21-23, 2005
3rd Annual Fast Product Development for the R&D Community, Toronto

July 18-23, 2004
12th International Congress of Immunology, Montreal

February 20-27, 2004
21st International Papillomavirus Conference, Mexico City

January 21-22, 2003
BioData 2003 (Geneva, Switzerland)

November 21-22, 2002
BioFuture 2002 (Vancouver, BC, Canada)

November 7-8, 2002
Workshop on Hepatitis B (Princeton, NJ, USA)

October 4-9, 2002
The HPV Clinical Workshop and 20th International Papillomavirus Conference (Paris, France)

May 6-8, 2002
The Fifth Annual Conference on Vaccine Research (Baltimore, MD, USA)


 
- -   - -   -
   
Nventa Biopharmaceuticals Corporation All Rights Reserved Copyright 2004-2008 -terms of use -|-sitemap-|-contact